Biomerica, Inc. reported earnings results for the third quarter and nine months ended February 28, 2023. For the third quarter, the company reported sales was USD 1.11 million compared to USD 7.66 million a year ago. Net loss was USD 1.65 million compared to USD 0.104168 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.12 compared to USD 0.01 a year ago.
For the nine months, sales was USD 4.23 million compared to USD 13.57 million a year ago. Net loss was USD 5.35 million compared to USD 2.77 million a year ago. Basic loss per share from continuing operations was USD 0.4 compared to USD 0.22 a year ago. Diluted loss per share from continuing operations was USD 0.4 compared to USD 0.22 a year ago.